awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47126394-17315A8E-F9C3-44C5-9A77-69BA44BA56B3
Q47126394-17315A8E-F9C3-44C5-9A77-69BA44BA56B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47126394-17315A8E-F9C3-44C5-9A77-69BA44BA56B3
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.
P2860
Q47126394-17315A8E-F9C3-44C5-9A77-69BA44BA56B3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47126394-17315A8E-F9C3-44C5-9A77-69BA44BA56B3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d9648a6f0cdd8c1b491b8ea77699d0ac72fdc0d
P2860
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation.